natgillin/translations-raw huggingface dataset:
By Implementing Decision 2013/707/EU [5], the Commission accepted the undertaking offered in the framework of an anti-dumping and an anti-subsidy proceedings concerning imports of crystalline silicon photovoltaic modules and key components (i.e. cells) originating in or consigned from the People's Republic of China.
Komisija je z Izvedbenim sklepom 2013/707/EU [5] sprejela zavezo, ponujeno v okviru protidampinškega in protisubvencijskega postopka v zvezi z uvozom fotonapetostnih modulov iz kristalnega silicija in njihovih ključnih sestavnih delov (tj. celic) s poreklom iz Ljudske republike Kitajske ali ki so od tam poslani.
Shanghai Chaori International Trading Co.
Družba Shanghai Chaori International Trading Co.
Ltd (‘company concerned’), TARIC additional code B872, whose undertaking was accepted by Implementing Decision 2013/707/EU, notified the Commission of its change of name to GCL System Integration Technology Co., Ltd.
Ltd („zadevna družba“), dodatna oznaka TARIC B872, katere zaveza je bila sprejeta z Izvedbenim sklepom 2013/707/EU, je Komisijo uradno obvestila o spremembi imena v GCL System Integration Technology Co., Ltd.
In 2014, the company concerned was declared bankrupt.
Leta 2014 je bil zoper zadevno družbo uveden stečajni postopek.
In February 2015, the company concerned was acquired by Jiangsu GCL Energy Co., Ltd which is part of a group of companies with the TARIC additional code B850.
Zadevno družbo je februarja 2015 prevzela družba Jiangsu GCL Energy Co., Ltd., ki je del skupine družb z dodatno oznako TARIC B850.
The company concerned argued that its change of name does not affect its right to continue to benefit from the individual duty rates applied to it.
Zadevna družba je trdila, da sprememba imena ne vpliva na njeno pravico do individualnih stopenj dajatev, ki se zanjo uporabljajo.
However, as a consequence of the acquisition, the company concerned not only changed the name to GCL System Integration Technology Co., Ltd, but also became part of the group of the companies with the TARIC additional code B850 [6].
Vendar pa je zaradi prevzema zadevna družba ne le spremenila ime v GCL System Integration Technology Co., Ltd., temveč je tudi postala del skupine družb z dodatno oznako TARIC B850 [6].
Both the company concerned and the group of the companies mentioned in recital 7 are subject to the undertaking.
Predmet zaveze sta tako zadevna družba kot skupina družb, navedena v uvodni izjavi 7.
Therefore, the Commission concluded that the change of name in no way affects the findings of Implementing Decision 2013/707/EU.
Zato je Komisija sklenila, da sprememba imena nikakor ne vpliva na ugotovitve iz Izvedbenega sklepa 2013/707/EU.
The Commission informed all interested parties of the essential facts and considerations on the basis of which it intended to amend Implementing Regulations (EU) No 1238/2013 and (EU) No 1239/2013.
Komisija je vse zainteresirane strani obvestila o bistvenih dejstvih in ugotovitvah, na podlagi katerih je nameravala spremeniti izvedbenih uredbah (EU) št. 1238/2013 in (EU) št. 1239/2013.
Those parties were granted a period within which they could make comments on the disclosure.
Za te zainteresirane strani je bil določen rok za pošiljanje pripomb v zvezi z razkritjem.
No party submitted comments.
Nobena stran ni predložila pripomb.
The measures provided for in this Decision are in accordance with the opinion of the Committee established by Article 15(1) of Regulation (EC) No 1225/2009,
Ukrepi, predvideni s tem sklepom, so v skladu z mnenjem Odbora, ustanovljenega s členom 15(1) Uredbe (ES) št. 1225/2009 –
The Annex to Implementing Decision 2013/707/EU is amended in accordance with the Annex to this Decision.
Priloga k Izvedbenemu sklepu 2013/707/EU se spremeni v skladu s Prilogo k temu sklepu.
Done at Brussels, 29 June 2016.
V Bruslju, 29. junija 2016
Council Implementing Regulation (EU) No 1238/2013 of 2 December 2013 imposing a definitive antidumping duty and collecting definitively the provisional duty imposed on imports of crystalline silicon photovoltaic modules and key components (i.e. cells) originating in or consigned from the People's Republic of China (OJ L 325, 5.12.2013, p. 1).
Izvedbena uredba Sveta (EU) št. 1238/2013 z dne 2. decembra 2013 o uvedbi dokončne protidampinške dajatve in dokončnem pobiranju začasne dajatve na uvoz fotonapetostnih modulov iz kristalnega silicija in njihovih ključnih sestavnih delov (tj. celic) s poreklom iz Ljudske republike Kitajske ali ki so od tam poslani (UL L 325, 5.12.2013, str. 1).
Council Implementing Regulation (EU) No 1239/2013 of 2 December 2013 imposing a definitive countervailing duty on imports of crystalline silicon photovoltaic modules and key components (i.e. cells) originating in or consigned from the People's Republic of China (OJ L 325, 5.12.2013, p. 66).
Izvedbena uredba Sveta (EU) št. 1239/2013 z dne 2. decembra 2013 o uvedbi dokončne izravnalne dajatve na uvoz fotonapetostnih modulov iz kristalnega silicija in njihovih ključnih sestavnih delov (tj. celic) s poreklom iz Ljudske republike Kitajske ali ki so od tam poslani (UL L 325, 5.12.2013, str. 66).
Commission Implementing Decision 2013/707/EU of 4 December 2013 confirming the acceptance of an undertaking offered in connection with the anti-dumping and anti-subsidy proceedings concerning imports of crystalline silicon photovoltaic modules and key components (i.e. cells) originating in or consigned from the People's Republic of China for the period of application of definitive measures (OJ L 325, 5.12.2013, p. 214).
Izvedbeni sklep Komisije 2013/707/EU z dne 4. decembra 2013 o potrditvi sprejetja zaveze, ponujene v okviru protidampinškega in protisubvencijskega postopka v zvezi z uvozom fotonapetostnih modulov iz kristalnega silicija in njihovih ključnih sestavnih delov (tj. celic) s poreklom iz Ljudske republike Kitajske ali ki so od tam poslani, za obdobje uporabe dokončnih ukrepov (UL L 325, 5.12.2013, str. 214).
Namely Konca Solar Cell Co.
In sicer Konca Solar Cell Co.
Council Decision (EU) 2016/1062
Sklep Sveta (EU) 2016/1062
on the conclusion on behalf of the European Union of the Sustainable Fisheries Partnership Agreement between the European Union and the Republic of Liberia and the Implementation Protocol thereto
o sklenitvi, v imenu Evropske unije, Sporazuma o partnerstvu o trajnostnem ribištvu med Evropsko unijo in Republiko Liberijo ter njegovega protokola o izvajanju
The Union and the Republic of Liberia negotiated a Sustainable Fisheries Partnership Agreement (hereinafter referred to as ‘the Agreement’) and an Implementation Protocol thereto (hereinafter referred to as ‘the Protocol’), granting Union vessels fishing opportunities in the waters over which the Republic of Liberia has sovereignty or jurisdiction in respect of fisheries.
Unija in Republika Liberija sta na podlagi pogajanj sklenili Sporazum o partnerstvu o trajnostnem ribištvu (v nadaljnjem besedilu: Sporazum) in Protokol o izvajanju Sporazuma (v nadalnjem besedilu: Protokol), s katerima se plovilom Unije dodelijo ribolovne možnosti v vodah, v katerih Republika Liberija v zvezi z ribištvom izvaja svojo suverenost ali pristojnost.
The Agreement and the Protocol were signed in accordance with Council Decision (EU) 2015/2312 [2] and apply on a provisional basis from 9 December 2015.
Sporazum in Protokol sta bila podpisana v skladu s Sklepom Sveta (EU) 2015/2312 [2] in se začasno uporabljata od 9. decembra 2015.
The Agreement set up a Joint Committee which is responsible for monitoring the performance, interpretation and application of the Agreement.
S Sporazumom se vzpostavi skupni odbor, ki je odgovoren za spremljanje izpolnjevanja, razlage in uporabe Sporazuma.
Furthermore, the Joint Committee may approve certain modifications to the Protocol.
Skupni odbor lahko poleg tega odobri določene spremembe Protokola.
In order to facilitate the approval of such modifications, it is appropriate to empower the Commission, subject to specific conditions, to approve them under a simplified procedure.
Da bi olajšali odobritev takšnih sprememb, je primerno, da se Komisijo pod posebnimi pogoji pooblasti, da jih po poenostavljenem postopku odobri.
The Agreement and the Protocol should be approved,
Sporazum in Protokol bi bilo treba odobriti —
The Sustainable Fisheries Partnership Agreement between the European Union and the Republic of Liberia and the Implementation Protocol thereto are hereby approved on behalf of the Union.
Sporazum o partnerstvu o trajnostnem ribištvu med Evropsko unijo in Republiko Liberijo ter Protokol o izvajanju Sporazuma se odobrita v imenu Unije.
Article 4
V Bruslju, 24. maja 2016
Done at Brussels, 24 May 2016.
Predsednik
For the Council
Odobritev z dne 10. maja 2016 (še ni objavljena v Uradnem listu).
The President
Sklep Sveta (EU) 2015/2312 z dne 30. novembra 2015 o podpisu, v imenu Evropske unije, in začasni uporabi Sporazuma o partnerstvu o trajnostnem ribištvu med Evropsko unijo in Republiko Liberijo ter njegovega protokola o izvajanju (UL L 328, 12.12.2015, str.
Consent of 10 May 2016 (not yet published in the Official Journal).
1).
Council Decision (EU) 2015/2312 of 30 November 2015 on the signing, on behalf of the European Union, and provisional application of the Sustainable Fisheries Partnership Agreement between the European Union and the Republic of Liberia and the Implementation Protocol thereto (OJ L 328, 12.12.2015, p. 1).
Generalni sekretariat Sveta bo datum začetka veljavnosti Sporazuma in Protokola objavil v Uradnem listu Evropske unije.
The date of entry into force of the Agreement and of the Protocol will be published in the Official Journal of the European Union by the General Secretariat of the Council.
PRILOGA
ANNEX
Obseg prenesenih pooblastil in postopek za oblikovanje stališča Unije v skupnem odboru
Scope of the empowerment and procedure for establishing the Union position in the Joint Committee
Komisija je pooblaščena za pogajanja z Republiko Liberijo in odobritev sprememb Protokola, če je to potrebno in ob upoštevanju točke 3 te priloge, glede naslednjih vprašanj:
The Commission shall be authorised to negotiate with the Republic of Liberia and, where appropriate and subject to complying with point 3 of this Annex, agree on modifications to the Protocol in respect of the following issues:
pregled ribolovnih možnosti ter posledično finančnega prispevka in odločitve glede poskusnega ribištva v skladu s členoma 6 in 7 Protokola;
review of fishing opportunities, and, consequently, of the relevant financial contribution, and decision on experimental fisheries, in accordance with Articles 6 and 7 of the Protocol;
odločitev o oblikah sektorske podpore v skladu s členom 4 Protokola;
decision on the modalities of the sectoral support in accordance with Article 4 of the Protocol;
odločitev o ukrepih za zagotovitev trajnostnega upravljanja ribolovnih virov v skladu s členom 5(5) Protokola;
decision on measures to ensure sustainable management of the fisheries resources in accordance with Article 5(5) of the Protocol;
odločitev glede tehničnih določb Protokola in Priloge k Protokolu v skladu s členom 6(2) Protokola.
decision on technical provisions of the Protocol and the Annex thereto in accordance with Article 6(2) of the Protocol.
V skupnem odboru Unija:
In the Joint Committee the Union shall:
deluje v skladu s cilji, ki jih želi doseči v okviru skupne ribiške politike;
act in accordance with the objectives pursued by the Union within the framework of the common fisheries policy;
spoštuje sklepe Sveta z dne 19. marca 2012 glede sporočila o zunanji razsežnosti skupne ribiške politike;
follow the Council conclusions of 19 March 2012 on a communication on the external dimension of the common fisheries policy;
spodbuja stališča, ki so skladna z ustreznimi pravili, sprejetimi v okviru regionalnih organizacij za upravljanje ribištva in skupnega upravljanja obalnih držav.
promote positions that are consistent with the relevant rules adopted by regional fisheries management organisations and in the context of joint management by coastal states.
Če je predvideno, da se na seji skupnega odbora sprejme sklep o spremembah Protokola iz točke 1, se sprejmejo ustrezni ukrepi, da se v stališču, ki se izrazi v imenu Unije, upoštevajo najnovejša statistična, biološka in druga ustrezna dognanja, posredovana Komisiji.
When a decision on modifications to the Protocol referred to in point 1 is intended to be adopted during a Joint Committee Meeting, the necessary steps shall be taken so as to ensure that the position to be expressed on behalf of the Union takes account of the latest statistical, biological and other relevant information transmitted to the Commission.
Službe Komisije v ta namen na podlagi teh dognanj in dovolj zgodaj pred ustrezno sejo skupnega odbora posredujejo Svetu ali njegovim pripravljalnim telesom v razpravo in odobritev dokument, v katerem navedejo podrobnosti predlaganega stališča Unije.
To this effect and based on that information, a document setting out the particulars of the proposed Union position shall be transmitted by the Commission services, in sufficient time before the relevant Joint Committee Meeting, to the Council or to its preparatory bodies for consideration and approval.
Glede vprašanj iz točke 1(a) se predvideno stališče Unije odobri s kvalificirano večino Sveta.
In respect of the issues referred to in point 1(a), the approval of the envisaged Union position by the Council shall require a qualified majority of votes.
V drugih primerih se predvideno stališče Unije iz pripravljalnega dokumenta šteje za dogovorjeno, razen če mu na sestanku pripravljalnega telesa Sveta, ali če je to prej, v 20 dneh po prejetju pripravljalnega dokumenta ne nasprotuje toliko držav članic, kot ustreza manjšini, ki lahko prepreči sprejetje odločitve.
In the other cases, the Union position envisaged in the preparatory document shall be deemed to be agreed, unless a number of Member States equivalent to a blocking minority objects during a meeting of the Council's preparatory body or within 20 days from receipt of the preparatory document, whichever occurs earlier.
V primeru takšnega nasprotovanja se zadeva predloži Svetu.
In case of such objection, the matter shall be referred to the Council.
Če med nadaljnjimi sestanki in tudi med samim sestankom ni mogoče doseči dogovora, s katerim bi zagotovili, da so v stališču Unije upoštevani novi dejavniki, se zadeva predloži Svetu ali njegovim pripravljalnim telesom.
If, in the course of further meetings, including on the spot, it is impossible to reach an agreement in order for the Union position to take account of new elements, the matter shall be referred to the Council or its preparatory bodies.
Komisija lahko v ustreznem roku sprejme kakršne koli ukrepe, potrebne v okviru nadaljnjega ukrepanja na podlagi sklepa skupnega odbora, ter po potrebi tudi objavi zadevni sklep v Uradnem listu Evropske unije in predloži predloge, potrebne za izvajanje navedenega sklepa.
The Commission is invited to take, in due time, any steps necessary as a follow-up to the decision of the Joint Committee, including, where appropriate, a publication of the relevant decision in the Official Journal of the European Union and a submission of any proposal necessary for the implementation of that decision.
Predsednik Sveta v imenu Unije pošlje uradni obvestili iz člena 16 Sporazuma oziroma člena 13 Protokola [3].Člen 3
The President of the Council shall, on behalf of the Union, give the notifications provided for in Article 16 of the Agreement and in Article 13 of the Protocol.
Ob upoštevanju določb in pogojev iz Priloge k temu sklepu je Komisija pooblaščena, da v imenu Unije odobri spremembe Protokola v skupnem odboru.
Council Implementing Decision (EU) 2016/1070
Izvedbeni sklep Sveta (EU) 2016/1070
on subjecting 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures
o uvedbi nadzornih ukrepov za 1-fenil-2-(pirolidin-1-il)pentan-1-on (α-pirolidinovalerofenon, α-PVP)
A risk assessment report on the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) was drawn up in accordance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction, and was subsequently submitted to the Commission and to the Council on 27 November 2015.
poročilo o oceni tveganja glede nove psihoaktivne snovi 1-fenil-2-(pirolidin-1-il) pentan-1-on (α-pirolidinovalerofenon, α-PVP) je bilo pripravljeno v skladu s Sklepom 2005/387/PNZ na posebnem sestanku razširjenega znanstvenega odbora Evropskega centra za spremljanje drog in zasvojenosti z drogami ter je bilo nato 27. novembra 2015 predloženo Komisiji in Svetu.
α-PVP is a potent psychostimulant, structurally related to cathinone, pyrovalerone and methylendioxypyrovaleron (MDPV), which are controlled under the 1971 United Nations Convention on Psychotropic Substances. α-PVP has been detected in all 28 Member States, as well as Turkey and Norway, and the information from seizures and collected samples indicate that it is mainly present in powder and tablet form.
α-PVP je močan psihostimulans, strukturno podoben katinonu, pirovaleronu in metilendioksipirovaleronu (MDPV), ki so predmet nadzora v skladu s Konvencijo Združenih narodov o psihotropnih snoveh iz leta 1971. α-PVP je bil odkrit v vseh 28 državah članicah ter v Turčiji in na Norveškem, informacije na podlagi zasegov in zbranih vzorcev pa nakazujejo, da je prisoten predvsem v obliki prahu in tablet.
The available information suggests that multi-kilogram quantities of α-PVP are imported into the Union drug market from China and then distributed across the Union.
Iz razpoložljivih informacij je razvidno, da se pošiljke z več kilogrami α-PVP uvažajo na trg z drogami v EU s Kitajske in se nato distribuirajo po vsej Uniji.
Two illicit production sites have been seized in a Member State, indicating that the capacity to manufacture α-PVP also exists within the Union.
Zaseg je bil opravljen na dveh lokacijah za nezakonito proizvodnjo v eni od držav članic, kar nakazuje na to, da zmogljivosti za proizvodnjo α-PVP obstajajo tudi v Uniji.
Eight Member States have reported a total of 115 deaths and 191 acute intoxications where α-PVP was detected.
Osem držav članic je poročalo o skupaj 115 smrtnih primerih in 191 akutnih zastrupitvah.
In most cases, the use of α-PVP was combined with other pharmacologically active substances, either intentionally or unintentionally.
V večini primerov se je α-PVP bodisi namerno bodisi nenamerno uporabljal v kombinaciji z drugimi farmakološko aktivnimi snovmi.
If α-PVP were to become more widely available and used, the implications for individual and public health could be significant.
Če bi α-PVP postal dostopnejši in bi se krog njegovih uporabnikov razširil, bi to lahko imelo resne posledice za zdravje posameznikov in javno zdravje.
The available data suggests that α-PVP is used by stimulant users in recreational settings as well as by high-risk drug users, including those injecting stimulants and opioids, and that polydrug use may be common among them.
Iz razpoložljivih podatkov izhaja, da α-PVP uporabljajo uporabniki stimulansov v okviru preživljanja prostega časa, prav tako pa tudi uživalci drog z visokim tveganjem, vključno s tistimi, ki si vbrizgavajo stimulanse in opioide, med njimi pa je lahko razširjena tudi uporaba več drog hkrati.
There is limited data on prevalence of drug use, long-term consequences and on the social risks associated with the substance.
Na voljo pa je malo podatkov o razširjenosti uporabe te droge, dolgoročnih posledicah in socialnih tveganjih, ki so povezana s to snovjo.
There is no available information or any published study assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects to those observed in other stimulants.
Na voljo ni nobenih informacij ali objavljenih študij, v okviru katerih bi bila na celovit način ocenjena zdravstvena tveganja, povezana s α-PVP, in sicer kronična in akutna strupenost, vendar so bili pri živalih opaženi podobni učinki kot pri drugih stimulansih.
Adverse symptoms observed in humans include tachycardia, hyperthermia, diaphoresis, agitation, convulsions or seizures, confusion and aggression.
Pri ljudeh so bili opaženi stranski učinki, kot so tahikardija, hipertermija, diaforeza, razdražljivost, konvulzije ali napadi, zmedenost in agresivnost.
Data from non-clinical studies suggest that α-PVP may have an abuse liability and possibly a dependence potential in humans.
Iz podatkov na podlagi predkliničnih študij je razvidno, da pri α-PVP obstaja nevarnost zlorabe te snovi, pri ljudeh pa lahko povzroči tudi odvisnost.
α-PVP has no established or acknowledged human or veterinary medical use.
α-PVP nima dokazane ali priznane medicinske ali veterinarske uporabe.
Apart from its use in analytical reference materials and in scientific research investigating its chemistry, pharmacology and toxicology as a result of its emergence on the drug market, there is no indication that it is being used for other purposes.
Ni znakov, da bi se ta snov uporabljala za druge namene, z izjemo uporabe v analitičnih referenčnih materialih in znanstvenih raziskavah, namenjenih proučevanju njenih kemijskih, farmakoloških in toksikoloških lastnosti, ki so bile opravljene zaradi njene prisotnosti na trgu z drogami.
Despite the limited scientific evidence available on α-PVP, the evidence and information on the health risks that the substance poses, as documented in its detection in fatalities and acute intoxications, provides sufficient grounds for subjecting α-PVP to control measures across the Union.
Kljub maloštevilnim znanstvenim dokazom, ki so na voljo o α-PVP, dokazi in informacije o zdravstvenih tveganjih, ki jih predstavlja ta snov, kakor so bili dokumentirani ob odkritju njene prisotnosti pri smrtnih žrtvah in akutnih zastrupitvah, zagotavljajo zadostno podlago za uvedbo nadzornih ukrepov za α-PVP po vsej Uniji.
Given that 16 Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and that five Member States use other legislative measures to control it, subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use could pose.
Ker je v 16 državah članicah uveden nadzor za α-PVP na podlagi nacionalne zakonodaje, ki je usklajena z obveznostmi iz Konvencije Združenih narodov o psihotropnih snoveh iz leta 1971, pet držav članic pa nadzor izvaja z drugimi zakonodajnimi ukrepi, bi uvedba nadzornih ukrepov za to snov po vsej Uniji pripomogla k preprečevanju nastanka ovir v čezmejnem sodelovanju na področju kazenskega pregona in pravosodja ter zagotovila zaščito pred tveganji, ki lahko nastanejo zaradi razpoložljivosti in uporabe te snovi.
Decision 2005/387/JHA confers upon the Council implementing powers with a view to giving a quick and expertise-based response at Union level to the emergence of new psychoactive substances detected and reported by the Member States, by subjecting those substances to control measures across the Union.
Sklep 2005/387/PNZ Svetu podeljuje izvedbena pooblastila, da bi se bilo mogoče na ravni Unije z uvedbo nadzornih ukrepov po vsej Uniji za nove psihoaktivne snovi hitro in strokovno odzvati na njihov pojav, ki ga države članice ugotovijo in o njem poročajo.
As the conditions and procedure for triggering the exercise of such implementing powers have been met, an implementing decision should be adopted in order to put α-PVP under control across the Union.
Pogoji za izvrševanje teh izvedbenih pooblastil so bili izpolnjeni in postopki upoštevani, zato bi bilo treba sprejeti izvedbeni sklep za uvedbo nadzornih ukrepov za α-PVP v celotni Uniji.
Denmark is bound by Decision 2005/387/JHA and is therefore taking part in the adoption and application of this Decision, which implements Decision 2005/387/JHA.
Sklep 2005/387/PNZ je za Dansko zavezujoč, zato sodeluje pri sprejetju in uporabi tega sklepa, s katerim se izvaja Sklep 2005/387/PNZ.